Watch Demo

Norway Lipid Modifying Drug Industry Outlook 2022 - 2026

See how Norway Lipid Modifying Drug performed compared to key markets such as South Korea, Spain and Italy.

Key Market Indicators

Norwegian sales of lipid-modifying medicines are projected to drop to $41 million by 2026. This is a 4% decrease from 2021, when the market was valued at $51 million. Since 2007, the Norwegian market has decreased by an average of 1.8% year on year. In 2021, Norway was the 16th largest market, behind Ireland at $51 million. Spain, Italy and Germany were the second, third and fourth largest markets, respectively.

Marketing Banner

Norway Lipid Modifying Drug Market Data and Forecasts

How much will Norway Lipid Modifying Drug Market grow to 2026?

Forecast: Lipid Modifying Medicine Sales in Norway
Forecast: Lipid Modifying Medicine Sales in Norway
Forecast: Lipid Modifying Medicine Sales in Norway
Forecast: Lipid Modifying Medicine Sales in Norway
Forecast: Lipid Modifying Medicine Use in Norway
More in Lipid Modifying Drug Industry for 2028